16.06.2022 - Clinical update call featuring LAVA-051 investigator Dr. Arnon Kater and Company management summarized initial Phase 1/2a clinical trial data presented at 2022 ASCO and EHA meetingsUTRECHT, The Netherlands and PHILADELPHIA, June 16, 2022 (GLOBE . Seite 1